8 employees
Bioantibody is a high-tech biotechnology firm that develops and manufactures antigens, antibodies, and downstream detection reagents.
2019
$15M
from 2 investors over 2 rounds
Bioantibody raised $15M on January 12, 2023
Investors: New Industry Ventures Venture Capital Fund and 梧桐树资本